The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|122|2|239-244

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.122, Iss.2, 2018-02, pp. : 239-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of metformin on anti‐Müllerian hormone in women with polycystic ovary syndrome: a secondary analysis of a randomized controlled trial

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 5, 2015-05 ,pp. : 547-551

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 6, 2015-06 ,pp. : 885-891

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of metformin in the treatment of polycystic ovary syndrome

By Genazzani Alessandro D   Ricchieri Federica   Lanzoni Chiara  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 577-593

Future Medicine

Access to resources Recommend Favorite

Combined metformin‐clomiphene in clomiphene‐resistant polycystic ovary syndrome: a systematic review and meta‐analysis of randomized controlled trials

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 9, 2015-09 ,pp. : 921-930

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D‐deficient women with polycystic ovary syndrome: a randomized double‐blind placebo‐controlled clinical trial

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 6, 2015-12 ,pp. : 888-894

John Wiley & Sons Inc

Access to resources Recommend Favorite